2024 annual financial data
Ascentage Pharma Group International 2024 Operating cash flow growth
Direct answer
Operating cash flow growth was Not calculable.
Operating income was -369,730,000 CNY and net income was -405,433,000 CNY.
Operating cash flow was -111,357,000 CNY.
Get free Ascentage Pharma Group International email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 980,650,000 CNY
- Operating income
- -369,730,000 CNY
- Net income
- -405,433,000 CNY
- Operating cash flow
- -111,357,000 CNY
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating marginView Net marginView Operating cash flow marginView all Ascentage Pharma Group International financial years